Description
The Abbott iScreen OFD Cotinine Test screens saliva for cotinine, the nicotine metabolite that reveals tobacco and nicotine exposure long after a cigarette is finished. Collection and testing happen in one step at the point of care, so wellness and insurance programs get an answer without a lab visit.
- Analyte – Cotinine, the nicotine metabolite
- Procedure – Collect and test in 1 step
- Read time – Results in as few as 10 minutes
- Packaging – 25 devices per box
About This Cotinine Screening Device
Cotinine screening answers a different question than a drug panel: whether a person has used nicotine recently enough for the metabolite to remain detectable in oral fluid. The OFD device collects and tests in a single step, which removes the transfer handling that complicates urine based cotinine checks. Observed oral fluid collection also eliminates privacy concerns and cross gender observation.
The wider OFD line screens recent drug use across amphetamine, cocaine, marijuana, methamphetamine, opiates, oxycodone and phencyclidine, and this configuration is dedicated to cotinine. The device is labeled for forensic use, and its result is a preliminary screen. A more specific alternate chemical method confirms a non negative result.
Features and Benefits
Screening Design
- Single step – Collect and test in one step at the point of collection
- Observed collection – Oral fluid collection eliminates privacy concerns and cross gender observation
- Fast reads – Results in as few as 10 minutes
Program Fit
- Nicotine programs – Built for tobacco and nicotine exposure screening in wellness and insurance programs
- Metabolite target – Cotinine detection reflects nicotine exposure after the parent compound clears
- Forensic labeling – The OFD line is labeled for forensic use
Product Specifications
Product Details
- Manufacturer: Abbott Toxicology
- Specimen: Oral fluid
- Format: Oral fluid screening device
- Analyte: Cotinine
- Results time: As few as 10 minutes
- Catalog number: I-DCT-B702
- Packaging: 25 devices per box
- Market: United States only
Browse related categories: diagnostic test kits and immunoassay test kits.
Why Choose This Product
Nicotine status drives real decisions in insurance underwriting and workplace wellness programs, and self reporting is unreliable. A one step saliva device gives those programs an observed, documented screen that fits into a short appointment.
- Observed and documented – Collection is watched, which supports defensible program records
- One step workflow – No specimen transfer between collection and test
- Ten minute answers – Results arrive inside the screening appointment
- Dedicated analyte – A cotinine only device avoids paying for a full drug panel
Frequently Asked Questions
What does a cotinine result show?
Cotinine is the metabolite the body produces from nicotine, so a positive screen indicates nicotine exposure from tobacco or other nicotine products. The result is a preliminary screen and does not identify the nicotine source.
How long does the test take?
Results read in as few as 10 minutes. Collection and testing happen in one step, so the appointment stays short.
Is the collection observed?
Oral fluid collection is observed by design, since the donor collects under direct watch. That observation eliminates privacy concerns and the need for cross gender observation.
Do positive results need confirmation?
Yes. The device provides a preliminary analytical result only. A more specific alternate chemical method, such as GC/MS or LC/MS-MS, confirms a non negative screen.
Is this the genuine Abbott OFD device?
This listing covers the genuine Abbott Toxicology device under manufacturer catalog number I-DCT-B702. It is sourced through the authorized distributor in original manufacturer packaging.
